345 search results for the keyword medicine supply notification in
Narrow your results
The current workforce pressures are leading to unplanned temporary closures that are beyond contractors’ control. In these circumstances, if contractors follow appropriate procedures to mitigate the effects of the closure on patients, the public, the NHS, and other community pharmacy [...]
Published on: 7th October 2022 | Updated on: 7th October 2022
This page contains information about the Pharmacy Contraception Service (PCS), which as commissioned by the NHS as an Advanced service. The PCS started on 24th April 2023, allowing the on-going supply of oral contraception (OC) from community pharmacies. From 1st [...]
Published on: 22nd September 2022 | Updated on: 10th April 2024
The following webpage sets out a list of detailed FAQs about NHSmail. The most frequently asked questions listed on this webpage are set out within this: NHSmail FAQ factsheet. Further information about NHSmail is available on: Community Pharmacy England’s main [...]
Published on: 16th August 2022 | Updated on: 9th January 2023
Following the announcement of thirteen HRT Serious Shortage Protocols (SSP), PSNC has been working with NHS Business Services Authority (NHSBSA) to understand whether claims for HRT SSPs are being submitted correctly and in accordance with the specific supporting guidance for [...]
Published on: 14th July 2022 | Updated on: 13th July 2022
This page provides information on the COVID-19 vaccination programme that pharmacies are taking part in. The current programme is the spring 2024 booster programme. Click on the header below for more information.
Published on: 30th June 2022 | Updated on: 12th April 2024
PSNC’s Dispensing & Supply team have created easy to use flow charts to assist pharmacists in selecting the correct SSP for HRT medicines. These charts also remind contractors of the correct SSP endorsement requirements (with examples) and charge status to [...]
Published on: 27th May 2022 | Updated on: 27th June 2022
Following the Department of Health and Social Care’s (DHSC) announcement of three new Serious Shortage Protocols (SSPs) for Hormone Replacement Therapy (HRT) medicines, PSNC has created a briefing titled ‘HRT Serious Shortage Protocols (SSPs) FAQs‘ to help pharmacists understand the requirements of [...]
Published on: 3rd May 2022 | Updated on: 5th June 2022
This page contains the answers to Frequently Asked Questions (FAQs) on the Smoking Cessation Service (SCS). Click on a heading below for more information
Published on: 24th February 2022 | Updated on: 6th July 2023
Read more about CP ITG and its work at: the Community Pharmacy IT Group (CP ITG) webpage. This ‘CP ITG workstream update (archive)‘ webpage sets out information following past CP ITG meetings based on past pharmacy IT bulletin. The bulletins [...]
Published on: 4th October 2021 | Updated on: 19th October 2023
A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 15 Issue 1 August 2021) has been published and includes articles on: COVID-19 vaccines: updates for July 2021 Letters and medicine recalls sent to healthcare professionals in [...]
Published on: 24th August 2021 | Updated on: 24th August 2021
This page contains information about the Smoking Cessation Service (SCS) which was commissioned as an Advanced service from 10th March 2022. Click on a heading below for more information
Published on: 23rd August 2021 | Updated on: 12th February 2024
Read more about CP ITG and its work at: the Community Pharmacy IT Group (CP ITG) webpage. This ‘CP ITG workstream update‘ webpage sets out information following CP ITG meetings based on the the latest pharmacy IT bulletin. The latest [...]
Published on: 28th June 2021 | Updated on: 19th October 2023
Ahead of the 2021/22 contract monitoring process, community pharmacy contractors are reminded of recent changes to the pharmacy Terms of Service. This article is part of a series of reminders. On 20th October 2020 new NHS regulations were laid to introduce changes [...]
Published on: 1st June 2021 | Updated on: 1st June 2021
The May 2021 Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 14 Issue 10) has been published and includes articles on: Levothyroxine: new prescribing advice for patients who experience symptoms on switching between different levothyroxine products COVID-19 [...]
Published on: 20th May 2021 | Updated on: 20th May 2021
A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 14 Issue 8 March 2021) has been published and includes articles on: Polyethylene glycol (PEG) laxatives and starch-based thickeners: potential interactive effect when mixed, leading to an [...]
Published on: 28th April 2021 | Updated on: 28th April 2021
